0001806270-23-000001.txt : 20230713 0001806270-23-000001.hdr.sgml : 20230713 20230713154249 ACCESSION NUMBER: 0001806270-23-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230713 DATE AS OF CHANGE: 20230713 EFFECTIVENESS DATE: 20230713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Venatorx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001590501 IRS NUMBER: 272782193 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-474330 FILM NUMBER: 231086724 BUSINESS ADDRESS: STREET 1: 30 SPRING MILL DRIVE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-644-8935 MAIL ADDRESS: STREET 1: 30 SPRING MILL DRIVE CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: VenatoRx Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131029 D/A 1 primary_doc.xml X0708 D/A LIVE 0001590501 Venatorx Pharmaceuticals, Inc. 30 SPRING MILL DRIVE MALVERN PA PENNSYLVANIA 19355 610-644-8935 DELAWARE VenatoRx Pharmaceuticals, Inc. Corporation true Christopher J Burns c/o Venatorx Pharmaceuticals, Inc. 30 Spring Mill Drive Malvern PA PENNSYLVANIA 19355 Executive Officer Director Timothy Haines c/o Venatorx Pharmaceuticals, Inc. 30 Spring Mill Drive Malvern PA PENNSYLVANIA 19355 Director Sergei Petukhov c/o Venatorx Pharmaceuticals, Inc. 30 Spring Mill Drive Malvern PA PENNSYLVANIA 19355 Director Martin Heidecker c/o Venatorx Pharmaceuticals, Inc. 30 Spring Mill Drive Malvern PA PENNSYLVANIA 19355 Director Anthony Meehan c/o Venatorx Pharmaceuticals, Inc. 30 Spring Mill Drive Malvern PA PENNSYLVANIA 19355 Executive Officer Daniel C Pevear c/o Venatorx Pharmaceuticals, Inc. 30 Spring Mill Drive Malvern PA PENNSYLVANIA 19355 Executive Officer Tomas Heyman c/o Venatorx Pharmaceuticals, Inc. 30 Spring Mill Drive Malvern PA PENNSYLVANIA 19355 Director Pharmaceuticals Decline to Disclose 06b true 0001590501-23-000001 2023-02-17 false true true true false 0 48246230 35008357 13237873 false 3 0 0 2550000 true false Venatorx Pharmaceuticals, Inc. Christopher J. Burns Christopher J. Burns President 2023-07-13